Duke University
Durham, North Carolina, 27705, United States
Location status: Recruiting
Location contact
Alicia Holloway
CONTACT
Andrada Neacsiu, PhD
PRINCIPAL_INVESTIGATOR
Elisabeth Conradt, PhD
PRINCIPAL_INVESTIGATOR
Janea Cato
CONTACT
NCT Number: NCT06963801
The goal of this study is to find out if improving emotion regulation skills use during pregnancy reduces maternal stress and improves heart rate.
The main questions it aims to answer are:
* Does improving emotion regulation skills during pregnancy reduce stress and improve the ability to cope? * How is a participant's heart rate affected by their ability to control their emotions during pregnancy?
Researchers will test the hypothesis that dialectical behavior therapy skills groups (DBT-P) will improve emotion regulation skills use as well as heart rate.
Participants will:
* Visit the clinic for 3 sessions at the beginning, middle and end of their pregnancy. * Compete surveys and interviews asking about their thoughts, feelings and how they cope with emotions. * Have their heart rate taken. * If assigned to the investigational group, they will complete weekly remote emotion regulation skills groups for 10 weeks and complete daily diary cards that ask about mood and any thoughts of self-harm. * Optional Element: Complete a 20-30min infant neurobehavior exam (NNNS exam) after delivery.
Interested in participating?
Request Info18 year–45 year
Female
Interventional
Not applicable
Durham, North Carolina, 27705, United States
Location status: Recruiting
Alicia Holloway
CONTACT
Andrada Neacsiu, PhD
PRINCIPAL_INVESTIGATOR
Elisabeth Conradt, PhD
PRINCIPAL_INVESTIGATOR
Janea Cato
CONTACT
The investigators' observational research with mothers with emotion dysregulation and their infants shows that poor emotion regulation skill use is a mechanism that likely confers risk for self-injurious thoughts and behaviors, depression, and anxiety in the mother and neurobehavioral and co-regulatory challenges in the infant. Emotion dysregulation is an impairing, early-emerging, transdiagnostic vulnerability factor that has intergenerational implications. Treatments have been developed for non-pregnant adults with emotion dysregulation but these are costly, time-intensive, and do not address the unique needs of pregnant people, highlighting an unmet therapeutic need. Through this innovative intervention, researchers will test whether targeting emotion regulation skills use during pregnancy will both improve postpartum emotion regulation, newborn neurobehavior, and mother-infant co-regulation. Early identification of the mechanisms implicated in risk. The researchers will deliver 10 weeks of DBT skills classes selected and adapted to meet the unique needs of pregnancy (DBT-P). The goal of this work is to improve perinatal mental health trajectories.
The premise of this study-that improving emotion regulation in pregnancy may disrupt intergenerational transmission of psychopathology-is informed by our research over the past two decades, including several NIH awards (R01MH119070, R01MH132210, R01DA049755, R21MH1090777, F31MH074196). The investigator' data reveal that maternal emotion dysregulation confers risk for mother. The research also shows that resting respiratory sinus arrhythmia (RSA), a physiological index of emotion dysregulation, can be improved via intervention in non-pregnant adults. The investigators propose that DBT-P will increase emotion regulation skills use or increase RSA in the mother (target engagement) leading to significant reductions in her emotion dysregulation prior to birth.
The primary study objectives are to recruit 100 pregnant women with high emotion dysregulation to receive either: (1) dialectical behavior therapy skills groups or an Assessment only control; and (2) to evaluate whether the treatment improved emotion regulation skills use as well as respiratory sinus arrhythmia.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
An established group-based pregnancy program focusing on improving nutrition, social, and medical support.
An emotional skills group where emotion regulation skills are taught in the context of the pregnancy and expected life with an infant.
Time frame: Baseline (Week 0), mid-treatment (Week 5), and post-treatment (Week 10)
The DERS is a 36-item measure scored on a 5-point Likert Scale. DERS scores range from 36-180 and enrollment in this study requires a baseline total DERS score of ≥88 which indicate greater difficulties in emotion regulation.
Time frame: Baseline (Week 0), mid-treatment (Week 5), and post-treatment (Week 10)
RSA is a peripheral index of parasympathetic nervous system influences on cardiac activity and is measured as the variability in heart rate that coincides with respiration.
Time frame: Baseline (Week 0), mid-treatment (Week 5), and post-treatment (Week 10)
Feasibility of the assessment schedule will include the percent of participation at all timepoints.
Time frame: Baseline (Week 0), mid-treatment (Week 5), and post-treatment (Week 10)
Feasibility of the assessment schedule will include the percent of missing data at all time points.
Time frame: Baseline (Week 0), mid-treatment (Week 5), and post-treatment (Week 10)
Feasibility of the intervention will be assessed by evaluating recruitment rates.
Time frame: Baseline (Week 0), mid-treatment (Week 5), and post-treatment (Week 10)
Feasibility of the intervention will be assessed by evaluating reasons for refusal. Collection of reasons for refusal to be obtained via subject self-report at each individual timepoint; expected attendance for 85% of sessions.
Time frame: Baseline (Week 0), mid-treatment (Week 5), and post-treatment (Week 10)
Feasibility of the intervention will be assessed by evaluating intervention adherence. Weekly assessment of intervention adherence conducted by clinicians based on subject completion of required homework assignments, daily diary entries and group session attendance.
Time frame: Baseline (Week 0), mid-treatment (Week 5), and post-treatment (Week 10)
Feasibility will be assessed by how many women completed all sessions.
Time frame: Baseline (Week 0), mid-treatment (Week 5), and post-treatment (Week 10)
Feasibility will be assessed by whether the interventionist can self-monitor for fidelity.
Time frame: Post-treatment (Week 10)
Acceptability will be assessed by participation rates.
Time frame: Post-treatment (Week 10)
Acceptability will be assessed by measuring participant satisfaction with the intervention (including completion of the intervention) using the Client Satisfaction Questionnaire. Scores are summed across items once. Items 2, 4, 5, and 8 are reverse scored. Total scores range from 8 to 32, with the higher number indicating greater satisfaction.
Time frame: Post-treatment (Week 10)
A 41-item original survey developed by DBT experts in the United States and Australia to measure participants' satisfaction with DBT delivered through telehealth. Items designed to assess relevance of care experience on a 5-pt scale from Not Relevant to Very Relevant. Responses anonymized and qualitative free-text fields provided for recommendations and comments for changes or improvements.
Contact information is provided by the study sponsor or research team.
Alicia Holloway
CONTACT
Janea Cato
CONTACT
Duke University
Other
Developing Pregnancy-specific Dialectical Behavior Therapy Skills to Promote Multigenerational Mental Health
Acronym: REACH
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07565129
Behavior, Eating Disorders
Barcelona, Spain
View Trial DetailsNCT05712057
Anxiety Disorders, Behavior
Durham, North Carolina, United States
View Trial DetailsNCT06333925
Anxiety Disorder, Anxiety Disorders
Durham, North Carolina, United States
View Trial DetailsNCT07119541
Borderline Personality Disorder, Emotion Dysregulation
Toronto, Ontario, Canada
View Trial Details